StockWatch
·

NATCO PHARMA LTD. Q3 FY25 Results

NATCOPHARMQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue474.8065.4%
Total Income651.1054.6%
Expenditure487.4021.0%
PBT163.7080.0%
Net Profit132.4080.4%
OPM-13.48%64.86pp
NPM20.33%26.82pp
EPS7.4380.3%
View full financials

Informational and educational content only. Not investment advice.